Alzamend Neuro, Inc. (ALZN)
USD 1.23
(-4.65%)
USD 1.23
(-4.65%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.26 Million | -8.92 Million | -6.61 Million | -2.71 Million | -2.34 Million | -1.04 Million |
| Net Income | -9.94 Million | -14.87 Million | -12.36 Million | -5.04 Million | -4.41 Million | -4.86 Million |
| Depreciation & Amortization | 50.74 Thousand | 23.06 Thousand | 3549.00 | - | - | - |
| Deferred income taxes | - | -1.7 Million | - | - | - | - |
| Stock-based compensation | 955.63 Thousand | 3.58 Million | 4.4 Million | 2.03 Million | 1.8 Million | 396.17 Thousand |
| Change in working capital | 670.66 Thousand | 2.34 Million | 1.32 Million | -152.45 Thousand | -299.34 Thousand | 1.22 Million |
| Other non-cash items | 714.00 | 1.7 Million | 8770.00 | 454.63 Thousand | 562.27 Thousand | 2.19 Million |
| Investing Cash Flow | -147.24 Thousand | - | -106.45 Thousand | 100.91 Thousand | 105 Thousand | 234.08 Thousand |
| Investments in PPE | -147.24 Thousand | - | -106.45 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | 5.37 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -147.24 Thousand | - | -5.37 Million | 100.91 Thousand | 105 Thousand | 234.08 Thousand |
| Financing Cash Flow | 3.65 Million | 200.00 | 18.85 Million | 4.45 Million | 2.28 Million | 308.72 Thousand |
| Debt repayment | -300 Thousand | - | -58.66 Thousand | -1918.00 | -16.8 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.25 Million | 989.33 Thousand | 18.91 Million | 2.1 Million | 2.28 Million | 236.02 Thousand |
| Other Financing Activities | 2.4 Million | -989.13 Thousand | 2200.00 | 2.35 Million | 16.93 Thousand | 72.69 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 54.93 Thousand | 1.7 Million | 693.58 Thousand | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 670.66 Thousand | -1.7 Million | 633.59 Thousand | -152.45 Thousand | -299.34 Thousand | 1.22 Million |
| Cash at beginning of period | 5.14 Million | 14.06 Million | 1.92 Million | 90.28 Thousand | 42.6 Thousand | 545 Thousand |
| Cash at end of period | 376.04 Thousand | 5.14 Million | 14.06 Million | 1.92 Million | 90.28 Thousand | 42.6 Thousand |
| Capital Expenditure | -147.24 Thousand | - | -106.45 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4.76 Million | -8.92 Million | 12.13 Million | 1.83 Million | 47.67 Thousand | -502.39 Thousand |
| Free Cash Flow | -8.41 Million | -8.92 Million | -6.72 Million | -2.71 Million | -2.34 Million | -1.04 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.94 Million | -851.52 Thousand | -2.66 Million | -2.9 Million | -3.52 Million | -14.87 Million |
| Depreciation & Amortization | 50.74 Thousand | 12.68 Thousand | 12.68 Thousand | 12.68 Thousand | 12.68 Thousand | 23.06 Thousand |
| Deferred income taxes | - | 1.3 Million | -1.57 Million | 142.6 Thousand | 129.23 Thousand | -1.7 Million |
| Stock-based compensation | 955.63 Thousand | 81.27 Thousand | 186.64 Thousand | 318.33 Thousand | 369.38 Thousand | 3.58 Million |
| Change in working capital | 670.66 Thousand | -669.85 Thousand | 431.43 Thousand | 1.06 Million | -152.49 Thousand | 2.34 Million |
| Other non-cash items | 714.00 | 107.36 Thousand | 1.57 Million | -142.6 Thousand | -129.23 Thousand | 1.7 Million |
| Investing Cash Flow | -147.24 Thousand | 147.24 Thousand | - | - | -147.24 Thousand | - |
| Investments in PPE | -147.24 Thousand | 147.24 Thousand | - | - | -147.24 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -147.24 Thousand | - | - | - | -147.24 Thousand | - |
| Financing Cash Flow | 3.65 Million | 1.51 Million | 2.11 Million | 18.08 Thousand | - | 200.00 |
| Debt repayment | -300 Thousand | -300 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.25 Million | 269.88 Thousand | 2.11 Million | 18.08 Thousand | - | 989.33 Thousand |
| Other Financing Activities | 2.4 Million | 1.51 Million | 2114.45 | 18.09 | - | -989.13 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 54.93 Thousand | 184.17 Thousand | - | - | -129.23 Thousand | 1.7 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 670.66 Thousand | -669.85 Thousand | 431.43 Thousand | 1.06 Million | 129.23 Thousand | -1.7 Million |
| Cash at beginning of period | 5.14 Million | 282.86 Thousand | 200.07 Thousand | 1.69 Million | 5.14 Million | 14.06 Million |
| Cash at end of period | 376.04 Thousand | 376.04 Thousand | 282.86 Thousand | 200.07 Thousand | 1.69 Million | 5.14 Million |
| Capital Expenditure | -147.24 Thousand | 147.24 Thousand | - | - | -147.24 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4.76 Million | 93.18 Thousand | 82.78 Thousand | -1.49 Million | -3.44 Million | -8.92 Million |
| Free Cash Flow | -8.41 Million | -1.27 Million | -2.03 Million | -1.51 Million | -3.44 Million | -8.92 Million |
TSI
BITTI
COGN3
4956
IPI
BCLIND